Literature DB >> 10706696

Induction of diabetes in nonobese diabetic mice by Th2 T cell clones from a TCR transgenic mouse.

M Poulin1, K Haskins.   

Abstract

We have produced a panel of cloned T cell lines from the BDC-2.5 TCR transgenic (Tg) mouse that exhibit a Th2 cytokine phenotype in vitro but are highly diabetogenic in vivo. Unlike an earlier report in which T cells obtained from the Tg mouse were cultured for 1 wk under Th2-promoting conditions and were found to induce disease only in NOD.scid recipients, we found that long-term T cell clones with a fixed Th2 cytokine profile can transfer disease only to young nonobese diabetic (NOD) mice and never to NOD.scid recipients. Furthermore, the mechanism by which diabetes is transferred by a Tg Th2 T cell clone differs from that of the original CD4+ Th1 BDC-2.5 T cell clone made in this laboratory. Whereas the BDC-2.5 clone rapidly causes disease in NOD.scid recipients less than 2 wk old, the Tg Th2 T cell clones can do so only when cotransferred with other diabetogenic T cells, suggesting that the Th2 T cell requires the presence of host T cells for initiation of disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706696     DOI: 10.4049/jimmunol.164.6.3072

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes.

Authors:  David H Wagner; Gisela Vaitaitis; Richard Sanderson; Michelle Poulin; Cathleen Dobbs; Kathryn Haskins
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

2.  The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model.

Authors:  L Wen; N Y Chen; J Tang; R Sherwin; F S Wong
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

3.  Pathogenicity of T helper 2 T-cell clones from T-cell receptor transgenic non-obese diabetic mice is determined by tumour necrosis factor-alpha.

Authors:  Jing He; Kathryn Haskins
Journal:  Immunology       Date:  2007-11-05       Impact factor: 7.397

4.  CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity.

Authors:  Thomas Calzascia; Marc Pellegrini; Albert Lin; Kristine M Garza; Alisha R Elford; Arda Shahinian; Pamela S Ohashi; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-14       Impact factor: 11.205

5.  Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice.

Authors:  Maximiliano Presa; Angela Zarama Ortiz; Nahir Garabatos; Cristina Izquierdo; Elisa I Rivas; Luc Teyton; Conchi Mora; David Serreze; Thomas Stratmann
Journal:  Eur J Immunol       Date:  2013-08-27       Impact factor: 5.532

6.  Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse.

Authors:  Hiroaki Moriyama; Norio Abiru; Johanna Paronen; Kamila Sikora; Edwin Liu; Dongmei Miao; Devasenan Devendra; Joshua Beilke; Roberto Gianani; Ron G Gill; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-18       Impact factor: 11.205

7.  Regulatory T Cells Control Th2-Dominant Murine Autoimmune Gastritis.

Authors:  Jessica Harakal; Claudia Rival; Hui Qiao; Kenneth S Tung
Journal:  J Immunol       Date:  2016-06-03       Impact factor: 5.422

Review 8.  CD4 T cell differentiation in type 1 diabetes.

Authors:  L S K Walker; M von Herrath
Journal:  Clin Exp Immunol       Date:  2015-07-28       Impact factor: 4.330

Review 9.  Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes?

Authors:  Ting-Ting Chang; Jaw-Wen Chen
Journal:  Cardiovasc Diabetol       Date:  2016-08-24       Impact factor: 9.951

10.  Rodent models for investigating the dysregulation of immune responses in type 1 diabetes.

Authors:  Feng-Cheng Chou; Heng-Yi Chen; Shyi-Jou Chen; Mei-Cho Fang; Huey-Kang Sytwu
Journal:  J Diabetes Res       Date:  2013-03-11       Impact factor: 4.011

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.